Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.25    2.75 (6.47%)
Bid:
44.50
Ask:
46.00
Spread: 1.50 (3.371%)
Market Cap: £86.82m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Management changes

8 Mar 2010 07:00

RNS Number : 2049I
Iofina PLC
08 March 2010
 



 

8 March 2010

Iofina plc

 ("Iofina" or "the Company" or "the Group")

 

MANAGEMENT CHANGE

 

 

The Board of Iofina announces that following an organisation review in the light of the broadening scope of the Company's business Lance Baller, currently Finance Director of the Group, has been appointed as CEO of the Group in place of David Schneider, with immediate effect. It is expected that a new appointment to the role of Finance Director will be made shortly.

 Also, effective immediately, Dr Tom Becker has been appointed as President of Iofina Chemical Inc.

Dr. Becker was the former vice president of Research and Development at H&S/Iofina Chemical. Iofina bought H&S Chemical in July 2009 for complete vertical integration into the iodine chemical derivatives market. Dr. Becker has conducted extensive research in both inorganic and organic halogen based chemistry. Dr. Becker has written a magnitude of published technical papers in his career. Prior to H&S Dr. Becker worked as an Oak Ridge Scholar on behalf of the US EPA and worked for various other chemical manufacturing companies. Dr. Becker earned a BS in Chemistry from Indiana University, and a PhD in Chemistry from the University of Cincinnati. He has extensive experience in scale-up of chemical processes from laboratory to pilot to full scale production and is the inventor on several chemical patents/patent applications.

Dr. Chris Fay CBE, Non Executive Chairman commented:

"We are continually looking to strengthen Iofina's management team and Board as evidenced by a number of personnel announcements. As the Company's focus now transitions from one of exploration and technology development towards production, contract negotiations and cash generation, the Board has concluded that Lance is best placed to lead the Company through this next phase of growth to drive shareholder value creation."

For further information, please contact:

Chris Fay, Non-Exec Chairman

Iofina plc

Tel: +44(0)20 3006 3135

 

Nominated Adviser:

James Harris/Angela Peace

Strand Hanson Limited

Tel: +44(0)20 7409 3494

 

Broker:

Rory Scott

Mirabaud Securities Limited

Tel: +44(0)20 7878 3360

 

Media Contact:

Klara Kaczmarek

Pelham Bell Pottinger

Tel: +44 (0)20 7337 1524

About Iofina

Iofina is involved in the exploration and production of both iodine and natural gas with complete vertical integration into the specialty chemical iodine derivatives business. It also provides third party brine stream operators with a turnkey solution to extract iodine. The presence of both iodine and natural gas has been discovered on acreages which the Company holds through its wholly owned subsidiary Iofina Natural Gas, Inc. The presence of both iodine and natural gas allows the Group to generate dual revenue streams over a single cost structure.

Iofina is traded on the London Stock Exchange's AIM Market under the ticker: IOF

www.Iofina.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUMCWUPUPUM
Date   Source Headline
2nd Oct 20132:40 pmRNSHolding(s) in Company
26th Sep 20133:32 pmRNSHolding(s) in Company
25th Sep 20137:00 amRNSHalf Yearly Report
19th Sep 20137:00 amRNSDirectorate Change
6th Sep 20137:00 amRNSNotice of Results
16th Aug 20137:00 amRNSBoard Appointment
2nd Aug 20138:30 amRNSIOSorb Patent Awarded
1st Aug 20137:00 amRNSOperational Update
4th Jul 20138:56 amRNSDirector/PDMR Shareholding
3rd Jul 20135:40 pmRNSChange of Registered Office
28th Jun 20132:05 pmRNSDirector/PDMR Shareholding
25th Jun 20138:15 amRNSProduction & Produced Water Congress 2013
24th Jun 20132:22 pmRNSHolding(s) in Company
24th Jun 201312:00 pmRNSResponse to Share Price Movement
19th Jun 20132:10 pmRNSResult of AGM
19th Jun 20137:00 amRNSAGM Statement
17th Jun 20135:01 pmRNSHolding(s) in Company
12th Jun 201310:08 amRNSBoard Changes
5th Jun 20137:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20137:00 amRNSCompletion of US$15m Convertible Bond Issue
8th May 20137:00 amRNSSuccessful Arrangement of US$15m Convertible Bond
7th May 20137:00 amRNSFinal Results
2nd May 20137:00 amRNSChange in Reporting Currency
29th Apr 20137:47 amRNSNotice of Final Results
29th Apr 20137:00 amRNSAtlantis Water Project Update
17th Apr 20137:00 amRNSHolding(s) in Company
15th Apr 20137:00 amRNSBoard Update
3rd Apr 20135:30 pmRNSHolding(s) in Company
28th Mar 20137:55 amRNSAtlantis Water Project
27th Mar 20134:09 pmRNSHolding(s) in Company
11th Mar 20135:19 pmRNSHolding(s) in Company
7th Mar 20137:00 amRNSOperational Update
11th Feb 20131:34 pmRNSHolding(s) in Company
16th Jan 20137:00 amRNSHolding(s) in Company
14th Jan 20137:00 amRNSAppointment of Non-Executive Director
11th Jan 20137:00 amRNSCommissioning of IO#2 IOsorbT Plant
20th Dec 20128:12 amRNSHolding(s) in Company
18th Dec 20129:00 amRNSHolding(s) in Company
4th Dec 20127:00 amRNSProduction Update
17th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSNotice of Results
16th Aug 20127:00 amRNSCommissioning of Plant
31st Jul 20127:00 amRNSCompletion of Construction of IO#1 IOsorb Plant
20th Jun 20122:25 pmRNSResult of AGM
20th Jun 20127:00 amRNSPurchase of Iodine Extraction Facility
7th Jun 20127:00 amRNSHolding(s) in Company
25th May 20127:00 amRNSPlacing to raise £4.3 million
25th May 20127:00 amRNSFinal Results
19th Apr 20127:56 amRNSAppointment of Investec as Nomad and Sole Broker
10th Apr 20129:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.